STREAMLINE HEA.SOL.DL-01

F:LV1 Germany Health Information Services
Market Cap
$9.17 Million
€8.93 Million EUR
Market Cap Rank
#36582 Global
#4514 in Germany
Share Price
€2.12
Change (1 day)
+0.00%
52-Week Range
€2.12 - €2.12
All Time High
€30.90
About

Streamline Health Solutions, Inc. offers health information technology solutions and associated services for hospitals and health systems in North America. The company offers RevID, a cloud-based automated revenue reconciliation software as a service (Saas) solution that delivers automated daily charge reconciliation, which identifies discrepancies between a provider's clinical and billing depart… Read more

STREAMLINE HEA.SOL.DL-01 (LV1) - Net Assets

Latest net assets as of : €- EUR

Based on the latest financial reports, STREAMLINE HEA.SOL.DL-01 (LV1) has net assets worth €- EUR as of .

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets €-
% of Total Assets 0%
Annual Growth Rate N/A
5-Year Change N/A
10-Year Change N/A
Growth Volatility N/A

STREAMLINE HEA.SOL.DL-01 - Net Assets Trend (None–None)

This chart illustrates how STREAMLINE HEA.SOL.DL-01's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for STREAMLINE HEA.SOL.DL-01 (None–None)

The table below shows the annual net assets of STREAMLINE HEA.SOL.DL-01 from None to None.

Year Net Assets Change
No yearly data available.

Equity Component Analysis

This analysis shows how different components contribute to STREAMLINE HEA.SOL.DL-01's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • No equity composition insights available.

STREAMLINE HEA.SOL.DL-01 Competitors by Market Cap

The table below lists competitors of STREAMLINE HEA.SOL.DL-01 ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in STREAMLINE HEA.SOL.DL-01's equity between the two most recent reporting periods.

Insufficient data available to analyze equity growth attribution.

Book Value vs Market Value Analysis

This analysis compares STREAMLINE HEA.SOL.DL-01's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Insufficient data available to analyze book value vs market value.

Capital Efficiency Dashboard

This dashboard shows how efficiently STREAMLINE HEA.SOL.DL-01 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Insufficient data available to analyze capital efficiency metrics.

Industry Comparison

This section compares STREAMLINE HEA.SOL.DL-01's net assets metrics with peer companies in the Health Information Services industry.

Industry Context

  • Industry: Health Information Services
  • Average net assets among peers: $1,807,324,866
  • Average return on equity (ROE) among peers: -12.22%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
STREAMLINE HEA.SOL.DL-01 (LV1) €- N/A N/A $784.17K
Schrödinger, Inc. (43Z) $557.09 Million -18.02% 0.36x $631.00 Million
DACHA STRATEGIC (7DC) $40.24 Million 0.65% 0.08x $81.97 Million
ABL Diagnostics Société anonyme (9BK0) $6.77 Million 0.80% 1.20x $371.65K
Zhejiang Taimei Medical Technology Co., Ltd. (A2V) $1.04 Billion -33.28% 0.39x $47.71 Million
ASCOM HLDG NA SF 0,50 (AH2N) $80.00 Million 16.88% 1.43x $190.62 Million
DocCheck AG (AJ91) $18.14 Million 3.32% 0.15x $18.00 Million
EM Systems Co. Ltd (EMO) $17.69 Billion 7.87% 0.33x $74.55 Million
Tempus AI (F3M) $-1.38 Billion 0.00% 0.00x $4.75 Billion
Pangenomic Health Inc. (LL3) $2.24 Million -118.14% 0.15x $4.82 Million
MeVis Medical Solutions AG (M3V) $17.83 Million 17.76% 0.45x $12.89 Million